Status:
COMPLETED
Safety and Performance Study of the CyPass System Applier Model 241
Lead Sponsor:
Transcend Medical, Inc.
Conditions:
Open Angle Glaucoma (OAG)
Eligibility:
All Genders
21+ years
Brief Summary
This is a retrospective chart review of cases in which the CyPass Micro-Stent was implanted using the Model 241 Applier. The objective of this study is to characterize and evaluate the safety of the M...
Eligibility Criteria
Inclusion
- Diagnosis of OAG
- CyPass Micro-Stent implantation (using the CyPass system 241) following uncomplicated phacoemulsification cataract removal and intraocular lens implantation
Exclusion
- Diagnosis of acute angle closure, traumatic, congenital, malignant, uveitic or neovascular glaucoma
- Prior incisional glaucoma surgery
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
172 Patients enrolled
Trial Details
Trial ID
NCT02228577
Start Date
August 1 2014
End Date
October 1 2014
Last Update
November 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinik for Augenheilkunde - Dietrich Bonhoeffer Klinikum
Neubrandenburg, Germany